The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading ->
African leaders must take the lead in the fight against Neglected Tropical Diseases, invest in their control and elimination, and foster cross-border collaboration to achieve the goal of eliminating NTDs as public health concerns by 2030. Neglected Tropical Diseases (NTDs) continue to pose a significant threat to the health and well-being of millions of people […] Continue reading ->
Despite the giant strides the world has made in combating the HIV epidemic, the high rate of infections among women and girls in sub-Saharan Africa, as well as childhood HIV infections, continue to hamper progress.   “Four thousand adolescent girls and young women acquired HIV every single week. That’s a crisis every single week. 3,100 of […] Continue reading ->
The World Health Organiztion (WHO) has been far too slow in providing financial, psychological and legal assistance to victims of sexual assault and exploitation committed by its staff in the Democratic Republic of Congo (DRC) during the 2018-2020 Ebola response, a veteran international investigator said at a WHO press conference on Friday. Hervé Gogo, presenting […] Continue reading ->
A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading ->